Digital And House-Call Diagnostics Will Transform MENA Healthcare Delivery

AN
AnalystHighTarget
AnalystHighTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
27 Jul 25
Updated
27 Jul 25
AnalystHighTarget's Fair Value
US$0.91
61.5% undervalued intrinsic discount
27 Jul
US$0.35
Loading
1Y
11.1%
7D
-2.8%

Author's Valuation

US$0.9

61.5% undervalued intrinsic discount

AnalystHighTarget Fair Value